Answers are grounded in this paper and cite their sources.
Randomized trial examines cognition outcomes in early life and aging, suggesting promising health effects.
less than five years old, scientific evidence on the use of MFGM and its polar lipids in cognitive neurodevelopment in early life and their potential effect in preventing neurodegeneration in old age. We conclude that MFGM is an interesting, abundant and exploitable source of relatively inexpensive bioactive molecules that could be properly formulated and utilized in the areas of neurodevelopment and cognitive decline. Sufficiently large randomized controlled trials are required before health-related statements can be made. However, research in this area is progressing rapidly and the evidence gathered points to biological, health-promoting effects.
No takes yet. Share an insight, caveat, or question.
Luque‐Uría et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: